Skip to main content

and
  1. Article

    Open Access

    Validation of response assessment according to international consortium for MDS/MPN criteria in chronic myelomonocytic leukemia treated with hypomethylating agents

    M Duchmann, T Braun, J-B Micol, U Platzbecker, S Park, S Pilorge in Blood Cancer Journal (2017)

  2. Article

    Open Access

    Karyotype complexity and prognosis in acute myeloid leukemia

    A complex aberrant karyotype consisting of multiple unrelated cytogenetic abnormalities is associated with poor prognosis in patients with acute myeloid leukemia (AML). The European Leukemia Net classification...

    F Stölzel, B Mohr, M Kramer, U Oelschlägel, T Bochtler, W E Berdel in Blood Cancer Journal (2016)

  3. Article

    Open Access

    Azacytidine impairs NK cell activity in AML and MDS patients undergoing MRD-based pre-emptive treatment after allogeneic stem cell transplantation

    C Schönefeldt, K Sockel, R Wehner, S Sopper, D Wolf, M Wermke in Blood Cancer Journal (2013)